SUSPEND Act Gets Moving
Client Alert | less than 1 min read | 11.13.13
On October 29, the House Oversight Committee passed out of committee the Stop Unworthy Spending, or SUSPEND, Act, legislation that would, effective FY2017, consolidate agency suspension and debarment offices into a single "Board of Suspension and Debarment" at GSA and unify the procurement and non-procurement suspension and debarment regulations, among other changes. The SUSPEND Act contains exceptions to allow offices of major agencies to remain in place in certain specified circumstances and for the SBA to retain its authority to suspend or debar entities for misrepresentation of small business status.
Contacts
Insights
Client Alert | 3 min read | 01.21.26
Atlantic Biologicals Opioid DPA: DOJ Continues Ramp Up of Criminal Corporate Healthcare Enforcement
On January 13, 2026, Miami-based pharmaceutical wholesaler Atlantic Biologicals Corporation entered into a two-year DPA, admitting to conspiracy to distribute and dispense controlled substances, including more than 14 million opioid doses to “pill mill” pharmacies in Texas at a markup. The DOJ and DEA underscored the company’s deliberate evasion of compliance checks and disregard for red flags signaling diversion.
Client Alert | 3 min read | 01.21.26
FedRAMP Proposes Updates to Authorization Process—Six New RFCs Released for Public Comment
Client Alert | 3 min read | 01.20.26
DoW Joins SBA’s Fight Against Alleged Pass-Through Fraud in the 8(a) Program
Client Alert | 3 min read | 01.20.26
Federal Government Challenges Minnesota Law Requiring Affirmative Action in State Government
